5/19
05:26 pm
amgn
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD [Yahoo! Finance]
Low
Report
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD [Yahoo! Finance]
5/19
05:15 pm
amgn
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
Low
Report
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
5/17
03:48 pm
amgn
FDA Roundup: May 17, 2024 [Yahoo! Finance]
Low
Report
FDA Roundup: May 17, 2024 [Yahoo! Finance]
5/17
01:55 pm
amgn
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC [Yahoo! Finance]
Low
Report
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC [Yahoo! Finance]
5/16
08:04 pm
amgn
U.S. FDA approves Amgen drug for small cell lung cancer [Globe and Mail, The (Toronto, Canada)]
Low
Report
U.S. FDA approves Amgen drug for small cell lung cancer [Globe and Mail, The (Toronto, Canada)]
5/16
06:46 pm
amgn
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Low
Report
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
5/16
05:10 pm
amgn
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer [The New York Times]
Low
Report
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer [The New York Times]
5/16
03:58 pm
amgn
FDA approves Amgen's treatment for most deadly form of lung cancer [CNBC]
Neutral
Report
FDA approves Amgen's treatment for most deadly form of lung cancer [CNBC]
5/2/2024
04:01 pm
amgn
amgen inc.
BEAT
Report
12.9%
amgen inc.
2/6/2024
04:01 pm
amgn
amgen inc.
BEAT
Report
-6.4%
amgen inc.
10/31/2023
07:00 am
amgn
amgen inc.
BEAT
Report
-2.6%
amgen inc.
8/3/2023
04:01 pm
amgn
amgen inc.
BEAT
Report
5.5%
amgen inc.
5/10
04:03 pm
amgn
Form DEFA14A AMGEN INC
Low
Report
Form DEFA14A AMGEN INC
5/9
07:09 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Santos Esteban
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Santos Esteban
5/9
07:08 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: REESE DAVID M
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: REESE DAVID M
5/9
07:07 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Khosla Rachna
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Khosla Rachna
5/9
07:07 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Miller Derek
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Miller Derek
5/9
07:06 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Grygiel Nancy A.
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Grygiel Nancy A.
5/9
07:04 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Griffith Peter H.
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Griffith Peter H.
5/9
07:03 pm
amgn
Form 4 AMGEN INC For: May 07 Filed by: Graham Jonathan P
Low
Report
Form 4 AMGEN INC For: May 07 Filed by: Graham Jonathan P
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register